Brief: Atossa Therapeutics Got Letter From Nasdaq Notifying That Co Was Not In Compliance With Nasdaq Listing Rule
28/09/2023 23:23
Sept 28 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS - ON SEPT 26, GOT LETTER FROM NASDAQ
NOTIFYING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary